Swing Trader Alert: IVZ Shows 8.15% Gain; Positive Momentum in Key Sectors
In the financial trading landscape, the swing trading strategy has been gaining momentum due to its short-term nature that captures gains from an asset's price swings. The allure of this strategy is evident in diversified sectors like Consumer, Energy, and Financials. At the heart of this trend is IVZ, which has impressively generated an 8.15% yield.
The IVZ stock recently set the markets abuzz when its Momentum Indicator turned positive on June 27, 2023. This shift is indicative of an upcoming upward trend, potentially signaling an opportune time for traders to consider taking a position in the stock or opting for call options.
Momentum indicators are technical tools often used in swing trading. They provide vital insights into the speed and strength of a stock's price movement. With IVZ's momentum indicator crossing the zero level, the anticipation is palpable for the stock to kick off a new upward swing.
Interestingly, this isn't an isolated event. Tickeron's A.I.dvisor has shed light on 98 similar instances where the momentum indicator turned positive. Out of these occurrences, the stock price moved higher in 77 cases. This pattern translates to a 79% chance of IVZ’s price moving upward in the coming days, showcasing the potency of the swing trading approach.
With a shift in IVZ’s momentum indicator, investors are presented with a potential opportunity to leverage this swing trading strategy. This strategy aims to capture smaller, short-term gains in a stock's price swing, rather than betting on a long-term upward trend. As such, timing is of the essence, and traders need to stay vigilant about indicators like the one IVZ has displayed.
This potential for high returns underlines the attractiveness of swing trading strategies in the consumer, energy, and financial sectors. It also highlights the significant role of tools such as momentum indicators in providing real-time insights that guide traders' decisions. With such promising prospects and sophisticated analytical tools, investors can optimize their trading strategy to better navigate and profit from the dynamic world of financial markets.
IVZ in upward trend: price expected to rise as it breaks its lower Bollinger Band on August 15, 2023
IVZ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where IVZ's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IVZ's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IVZ advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 13, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on IVZ as a result. In of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IVZ turned negative on September 20, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IVZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for IVZ entered a downward trend on August 31, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.597) is normal, around the industry mean (3.502). P/E Ratio (10.753) is within average values for comparable stocks, (31.346). Projected Growth (PEG Ratio) (2.696) is also within normal values, averaging (4.179). Dividend Yield (0.052) settles around the average of (0.071) among similar stocks. P/S Ratio (1.199) is also within normal values, averaging (77.915).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IVZ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IVZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a provider of investment management services
Industry InvestmentManagers
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBSA | 46.70 | -0.04 | -0.08% |
| JPMorgan BetaBldrs 1-5 Yr US Aggt Bd ETF | |||
| TACK | 23.29 | -0.15 | -0.65% |
| Fairlead Tactical Sector | |||
| XLF | 34.49 | -0.24 | -0.69% |
| Financial Select Sector SPDR® ETF | |||
| IYC | 69.14 | -0.51 | -0.73% |
| iShares US Consumer Discretionary ETF | |||
| FTQI | 19.39 | -0.15 | -0.77% |
| First Trust Nasdaq BuyWrite Income ETF | |||
IVZ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IVZ has been closely correlated with BEN. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if IVZ jumps, then BEN could also see price increases.
| Ticker / NAME | Correlation To IVZ | 1D Price Change % | ||
|---|---|---|---|---|
| IVZ | 100% | -1.51% | ||
| BEN - IVZ | 84% Closely correlated | -1.22% | ||
| BLK - IVZ | 83% Closely correlated | -0.80% | ||
| TROW - IVZ | 79% Closely correlated | -1.74% | ||
| JHG - IVZ | 79% Closely correlated | -2.53% | ||
| APAM - IVZ | 75% Closely correlated | +0.95% | ||
More | ||||